Propiedad y actividad de insiders de Fulgent Genetics, Inc. (FLGT): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $21.63 |
| Capitalización | $614M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-01 | Kim Paul | F-InKind | 2,087 | $41K |
| 2026-09-01 | Hsieh Ming | F-InKind | 4,392 | $86K |
| 2026-09-02 | Gao Hanlin | S-Sale | 1,673 | $33K |
| 2026-09-02 | Xie Jian | S-Sale | 2,127 | $42K |
| 2026-08-26 | Hsieh Ming | F-InKind | 2,949 | $58K |
| 2026-08-26 | Kim Paul | F-InKind | 1,168 | $23K |
| 2026-08-27 | Xie Jian | S-Sale | 1,193 | $24K |
| 2026-08-27 | Gao Hanlin | S-Sale | 939 | $19K |
| 2026-07-26 | Kim Paul | F-InKind | 2,747 | $54K |
| 2026-07-26 | Xie Jian | F-InKind | 4,361 | $86K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $7.9M | $6.5M | $6.7M | $12.0M | $87.4M | $164.9M | $79.5M | $97.5M | $55.1M | $50.2M |
| Inversiones a Corto | $38.6M | $34.9M | $30.7M | $16.3M | $211.9M | $285.6M | $446.7M | $326.7M | $203.0M | $285.9M |
| Cuentas por Cobrar | $4.4M | $4.1M | $6.2M | $7.2M | $204.1M | $143.3M | $75.1M | $57.4M | $77.0M | $91.6M |
| Inventario | $322000 | $231000 | $314000 | $277000 | $16.5M | $12.2M | $4.3M | $5.8M | $8.4M | $10.6M |
| Activos Corrientes | $50.8M | $45.4M | $43.4M | $37.1M | $523.6M | $612.0M | $627.9M | $507.8M | $353.6M | $550.5M |
| Inmovilizado Material | $6.2M | $7.3M | $6.4M | $8.6M | $40.2M | $62.3M | $81.4M | $83.5M | $105.5M | $112.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | $50.9M | $143.0M | $22.1M | $22.1M | $25.1M |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | $35.9M | $150.6M | $143.1M | $135.0M | $133.3M |
| Activos Totales | $58.0M | $57.0M | $55.0M | $88.8M | $700.5M | $1.28B | $1.39B | $1.24B | $1.22B | $1.21B |
| Cuentas por Pagar | $2.8M | $2.1M | $1.3M | $1.6M | $26.5M | $20.5M | $23.1M | $15.4M | $18.4M | $18.7M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $15.0M | $21.3M | $20.6M | $1.2M | $412000 | $476000 |
| Pasivos Corrientes | $3.6M | $2.9M | $2.7M | $3.7M | $130.1M | $105.3M | $88.1M | $73.0M | $72.9M | $85.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $3.4M | $3.0M | $2.5M | $2.0M |
| Pasivos Totales | $3.6M | $2.9M | $2.7M | $6.0M | $131.1M | $112.8M | $116.2M | $102.0M | $90.8M | $106.8M |
| Reservas | -$55.2M | -$57.7M | -$63.0M | -$63.4M | $150.9M | $657.6M | $801.0M | $633.2M | $590.5M | $530.0M |
| Patrimonio Neto | $54.5M | $54.0M | $52.3M | $82.8M | $569.4M | $1.16B | $1.27B | $1.14B | $1.13B | $1.11B |
| Deuda Total | 0 | 0 | 0 | $2.7M | $15.9M | $21.3M | $38.9M | $15.3M | $8.5M | $7.7M |
| Deuda Neta | -$46.5M | -$41.4M | -$37.4M | -$25.6M | -$283.5M | -$429.2M | -$487.3M | -$408.9M | -$249.6M | -$328.4M |
| Capital Circulante | $47.3M | $42.4M | $40.6M | $33.4M | $393.5M | $506.6M | $539.8M | $434.8M | $280.7M | $465.5M |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 6.34 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 5.63 |
Rentabilidad
| Rentabilidad sobre capital | -7.87% |
| Rentabilidad sobre capital invertido | -11.05% |
| Rentabilidad sobre activos | -7.75% |
| Margen bruto | 35.58% |
| Margen operativo | -37.08% |
| Margen neto | -26.05% |
Empresas relacionadas: ARVN · AVXL · BFLY · CDNA · CSTL · DRIO · MYGN
Explorar sector: Healthcare · Medical - Diagnostics & Research
Más secciones de FLGT: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones